Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

New genetic map helps track aggressive prostate cancer development (opens in a new tab)

news-medical.net · 2026-09-09

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Claim 1 of 8Not checkedResearchers analyzed the genetic material of 1,000 prostate cancer patients and identified a new way of tracking how the disease develops.View evidenceHide evidence

As stated1,000 patients

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 8Not checkedThe approach could help identify patients at high risk of developing aggressive prostate cancer.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 8Not checkedThe researchers say they created a map of the biological processes that drive prostate cancer.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 8Not checkedEight types of genetic fingerprints account for 85 per cent of all prostate cancer cases.View evidenceHide evidence

As stated85 per cent

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 5 of 8Not checkedFour of the eight patterns were associated with a higher risk of the cancer spreading, particularly in tumours driven by testosterone.View evidenceHide evidence

As statedfour of eight patterns

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 6 of 8Not checkedThe team says errors during DNA replication appear to play a much greater role in prostate cancer development than previously recognized, and around one-third of tumours are caused by damage that occurs when DNA is copied.View evidenceHide evidence

As statedaround one-third of tumours

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 7 of 8Not checkedThe findings could eventually help predict which patients are most likely to benefit from different treatments, including chemotherapy or hormone therapy.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 8 of 8Not checkedThe authors stress that the findings will not change patient treatment immediately and must first be validated in clinical studies.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Integrated signatures define mutational processes in prostate cancer

Nature · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 38 candidate papers

Candidate

Author response for "High-level ab initio characterization of the multichannel Cl(2P3/2) + C2H5I reaction"

2026 · Crossref

Source (opens in a new tab)

And 32 more candidates considered.